TABLE 3.
Interruptedb CDS(s) and plasmidc | Avg generation time (h) ± SD with MMAa provided as: |
||
---|---|---|---|
C + N source | C source | N source | |
None | |||
pCM80 | 18.9 ± 0.9 | 18.0 ± 0.4 | 4.4 ± 0.2 |
pME8280 | 16.2 ± 0.6 | 15.3 ± 0.3 | 3.3 ± 0.2 |
pME8285 | 17.5 ± 0.9 | 18.8 ± 1.6 | 3.5 ± 0.2 |
METDI2327 | |||
pCM80 | No growth | No growth | 42.6 ± 1.2 |
pME8280 | 16.9 ± 0.7 | 15.9 ± 0.3 | 4.7 ± 0.3 |
pME8285 | 20.2 ± 0.8 | 16.5 ± 1.3 | 4.0 ± 0.3 |
METDI2327, METDI4690 | |||
pCM80 | No growth | No growth | 41.7 ± 1.2 |
pME8285 | 21.5 ± 0.5 | 19.2 ± 1.5 | 4.0 ± 0.1 |
MMA was added as the C or N source at 20 or 1.5 mM, respectively. In controls, succinate at 5 mM and (NH4)2SO4 at 1.5 mM were provided as C and N sources, respectively. Similar growth of all strains on succinate (5 mM) and (NH4)2SO4 (1.5 mM) was observed (generation time, 3.4 ± 0.3 h).
Interruption of METDI4690 alone conferred no phenotype with MMA as the C or N source (Table 2, mutant DM4Δmetdi4690).
pCM80, empty expression vector; pME8280, pCM80 for gmaS expression of METDI2327; pCM8285, pCM80 for expression of METDI4690.